Assignee
MALCOLM THOMAS
US·1 granted patent·9 pending applications·0 citations·filing 2018–2023
Top patents by PatentIndex Score
10 records- 0159US2025387515A1Hypoimmunogenic biomimetic nanovesicle gene editing system for hiv infectionMALCOLM THOMAS·Filed 2023·Application pending·0 cites
- 0258US2025332115A1Controlled expression of therapeutically relevant biomolecules for lumen-localized payloads in biomimetic nanovesicles and exosomesMALCOLM THOMAS·Filed 2023·Application pending·0 cites
- 0355US2025242046A1Allogeneic hypoimmune biomimetic nanovesicle for the treatment of cancerMALCOLM THOMAS·Filed 2023·Application pending·0 cites
- 0446US12357704B2Tailored hypoimmune nanovesicular delivery systems for cancer tumorsMALCOLM THOMAS·Filed 2020·Granted Jul 15, 2025·0 cites·20 claims
- 0545US2023144704A1Tailored hypoimmune nanovesicular delivery systems for cancer tumors, hereditary and infectious diseasesMALCOLM THOMAS·Filed 2022·Application pending·0 cites
- 0644US2024307317A1Tailored hypoimmunenanovesicular delivery systems for cancer tumore, hereditary and infectious diseasesMALCOLM THOMAS·Filed 2022·Application pending·0 cites
- 0741US2019338315A1CLOAKED CRISPRsMALCOLM THOMAS·Filed 2019·Application pending·0 cites
- 0840US2019336617A1CRISPRs IN SERIES TREATMENTMALCOLM THOMAS·Filed 2019·Application pending·0 cites
- 0940US2022040106A1Tailored hypoimmune nanovesicular delivery systems for cancer tumors, hereditary and infectious diseasesMALCOLM THOMAS·Filed 2021·Application pending·0 cites
- 1038US2019071673A1CRISPRs WITH IMPROVED SPECIFICITYMALCOLM THOMAS·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →